Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1906 to 1920 of 8236 results

  1. Nivolumab with BMS-986205 and chemotherapy for neoadjuvant treatment of muscle-invasive bladder cancer [ID6321]

    In development Reference number: GID-TA11336 Expected publication date: TBC

  2. Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)

    In development Reference number: GID-NG10450 Expected publication date: TBC

  3. Sarizotan for the treatment of respiratory symptoms associated with Rett syndrome [ID1506]

    Awaiting development Reference number: GID-TA10662 Expected publication date: TBC

  4. Cutting blocks for total knee arthroplasty

    Topic prioritisation

  5. Cervical ripening ballon for the induction of labour in women who have previously undergone cesarean section

    Topic prioritisation

  6. Implantable Vagus Nerve Stimulator in Heart Failure

    Topic prioritisation

  7. Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosis

    Topic prioritisation

  8. Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in children

    Topic prioritisation

  9. Implanting a baroreceptor stimulation device for resistant hypertension

    In development Reference number: GID-IP1180 Expected publication date: TBC

  10. Degradable surgical implant

    Topic prioritisation

  11. Peroral endoscopic myotomy (POEM) for achalasia

    Topic prioritisation

  12. Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica

    Topic prioritisation

  13. Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624]

    Awaiting development Reference number: GID-TA11816 Expected publication date: TBC

  14. Talquetamab with daratumumab for treating relapsed or refractory multiple myeloma after 1 or more lines of treatment including a proteasome inhibitor and lenalidomide [ID6625]

    Awaiting development Reference number: GID-TA11815 Expected publication date: TBC

  15. Psoriasis: assessment and management (CG153)

    In development Reference number: GID-NG10448 Expected publication date: TBC